Uptake of antineoplastic agents into large unilamellar vesicles in response to a membrane potential.
Many drugs exhibit lipophilic and cationic (basic) characteristics. Previous studies have shown that lipophilic cations can be accumulated into model membrane 'liposomal' (vesicular) systems in response to establishing a membrane potential (inside negative) across the vesicle membrane. We demonstrate here that the anticancer drugs, adriamycin and vinblastine, can be rapidly accumulated into egg phosphatidylcholine large unilamellar vesicles in response to a valinomycin-dependent K+ diffusion potential (delta psi) to achieve high effective interior concentrations. Further, trapping efficiencies approaching 100% can be easily achieved. The influence of lipid composition and the requirement for valinomycin have been examined for adriamycin. Equimolar cholesterol levels inhibit the uptake process at 20 degrees C. However, incubation at higher temperature results in enhanced uptake. Similarly, the presence of egg phosphatidylserine or incubation at elevated temperatures results in significant adriamycin uptake in the absence of valinomycin. It is shown that the adriamycin retention time in the vesicles is enhanced by an order of magnitude or more when actively trapped by the presence of a membrane potential in comparison to passive trapping procedures. It is suggested that such active trapping procedures may be of use for loading liposomal systems for drug delivery applications, and may provide avenues for controlled release of encapsulated material.
D000970:Antineoplastic Agents / Q000378:metabolism*; D002784:Cholesterol; D003561:Cytarabine / Q000378:metabolism; D004317:Doxorubicin / Q000378:metabolism; D008081:Liposomes / Q000378:metabolism*; D008564:Membrane Potentials; D008727:Methotrexate / Q000378:metabolism; D010539:Permeability; D011188:Potassium / Q000378:metabolism; D011663:Pulmonary Surfactants; D014634:Valinomycin / Q000494:pharmacology; D014747:Vinblastine / Q000378:metabolism
D000970:Antineoplastic Agents; D008081:Liposomes; D011663:Pulmonary Surfactants; D003561:Cytarabine; D014634:Valinomycin; D014747:Vinblastine; D004317:Doxorubicin; D002784:Cholesterol; D011188:Potassium; D008727:Methotrexate